SCHEMBL5920141

SCHEMBL5920141

CCCCC(C=Nc1ccc(CC)c(CC)c1)=Nc1ccc(CC)c(CC)c1.CCCCCCCCNc1ccc2cc(O)c(O)cc2c1CCCC

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PLK1 P53350 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4866830 0.99 PLK1 (0.31) PLK1
SCHEMBL5919945 0.84 HSD17B10 (0.31) —
SCHEMBL4868798 0.83 HSD17B10 (0.30) —
SCHEMBL5920313 0.83 CYP3A4 (0.31) —
SCHEMBL5677611 0.83 TYR (0.34) —
SCHEMBL4869166 0.82 MEN1 (0.30) —
SCHEMBL4869325 0.82 TYR (0.33) —
SCHEMBL5919811 0.80 — —
SCHEMBL4868549 0.79 — —
SCHEMBL5678097 0.78 CNR1 (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III ZHAO BAIYI 2006-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III COMT, CD69, SPR PLK1 2886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback